Name | Humantenmine |
---|---|
Synonyms |
(3S,3'R,3a'S,6'R,8a'S)-2'-ethyl-1-methoxy-3a',4',8',8a'-tetrahydro-3'H,6'H-spiro[indole-3,7'-[3,6]methanooxepino[4,3-b]pyrrol]-2(1H)-one
Gelsedine, 4,20-didehydro- (1'R,3S,4'S,7'R,8'S)-6'-Ethyl-1-methoxyspiro[indole-3,2'-[10]oxa[5]azatricyclo[5.3.1.0]undec[5]en]-2(1H)-one |
Description | Humantenmine, a newalkaloid isolated from Gelsemium elegan Banth in China, has the potential for pain and rheumatic arthritis treatment[1][2]. |
---|---|
Related Catalog | |
In Vitro | Humantenmine (HMT) decreases the 14-day survival rate of the mice to 17% after they are intragastrically treated with HMT, along with hepatic injury and increasing alanine aminotransferase (ALT)/aspartate aminotransferase (AST) levels. CYP3A4/5 mediates the metabolism and detoxification of HMT[1][2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 463.6±55.0 °C at 760 mmHg |
Molecular Formula | C19H22N2O3 |
Molecular Weight | 326.390 |
Flash Point | 234.2±31.5 °C |
Exact Mass | 326.163055 |
PSA | 51.13000 |
LogP | 3.68 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.712 |
Hazard Codes | Xi |
---|